Silvia de Sanjose

S de Sanjosé is a Medical doctor, Family Practitioner and Epidemiologist. She has been involved in the research of infections and cancer since 1998 after her PhD at the London University. She has been involved in multiple international studies that led to the identification of Human Papilloma Virus to be considered as the necessary cause of cervical cancer and that helped to identify the most relevant worldwide HPV genotypes for the construction of the existing HPV vaccines. She coordinates the evaluation of the introduction of HPV testing as primary screening tool in cervical cancer screening in Catalonia since 2006. She has been involved in guidelines and position papers related to HPV within the WHO. She is now the President of the International Papillomavirus Society. She has published over 350 peer reviewed papers.